Comunicati Stampa
Salute e Benessere

Genomics Market to Reach $70.52 Billion by 2031, Driven by Increasing Incorporation of Genomic Data in Clinical Workflows and Increasing Funding and Investments in Genomics Projects - Exclusive Report by Meticulous Research®

Download FREE PDF Brochure Of Genomics Market –https://www.meticulousresearch.com/download-sample-report/cp_id=1262 Download FREE PDF Brochure Of Genomics Market–https://www.meticulousresearch.com/download-sample-report/cp_id=1262 The rising prevalence of genetic diseases, the increasing incorporation of genomic data in clinical workflows, increasing funding and investments in genomics projects, growing applications of genomics in the healthcare sector, rising pharmaceutical R&D...
REDDING, Calif., (informazione.news - comunicati stampa - salute e benessere)


https://www.meticulousresearch.com/download-sample-report/cp_id=1262

The rising prevalence of genetic diseases, the increasing incorporation of genomic data in clinical workflows, increasing funding and investments in genomics projects, growing applications of genomics in the healthcare sector, rising pharmaceutical R&D expenditures, and increasing healthcare spending are key factors driving the growth of the genomics market. However, concerns over the security & privacy of genomic data and the lack of standardized approaches in genomics are factors restraining the growth of this market.

Furthermore, the rising adoption of personalized medicines and gene therapies is expected to create opportunities for the players operating in the genomics market. However, the shortage of skilled bioinformatics & genomics personnel and the commercialization & scaling of genomic technologies are major challenges impacting market growth. READ MORE

Pharmaceutical and biotechnology companies have been increasingly focused on genomic research since 2003 – the year of completion and publishing of the full sequence of the entire human genome. Furthermore, increasing funding for genomic research, the development of advanced sequencing technologies & bioinformatics tools, and the reducing costs of genomic studies are generating opportunities for pharmaceutical and biotechnology companies to engage more in the research and development of personalized/precision medicine, targeted therapeutics, and vaccines. These factors have also helped companies as well as academic & research institutes to conduct more studies focused on mapping and identifying variants and studying the mechanisms of various rare and genetic diseases.

https://www.meticulousresearch.com/request-sample-report/cp_id=1262

The pharmaceutical industry is also investing in genomic data-sharing initiatives to accelerate the research and development of novel personalized therapies. Also, research and academic institutes are partaking in genomic studies and collaborating with key pharmaceutical companies to exchange genomic data and discover new personalized therapies for various rare and genetic diseases. Some of the recent funding and investments supporting genomics studies are as follows:

The ability to sequence the genes of any organism for clinical and research purposes has proved to be a game changer for public health. Portable handheld sequencing devices are paving the way for the growth of the genomics market, making sequencing cheaper, simpler, and faster without the need for large clinical laboratories. Real-time sequencing has enabled researchers and physicians to quickly access sequencing data and act instantly. Portable nanopore-based sequencers can sequence the entire genome in less than $1,000 . Additionally, automating NGS library preparation has helped researchers improve their library quality and achieve consistent yields, enabling the generation of reliable and reproducible NGS data.

NGS automation has also enhanced the efficiency of sequencing in terms of time and cost. The risk of contamination is greatly decreased by reducing human interactions with reagents and samples. According to a study that analyzed the cost breakdown for genome sequencing, lab personnel account for around 15% of the total cost of sequencing in a conventional clinical laboratory. A similar study showed that when an automated system is used for sample preparation, the cost of laboratory personnel decreases to around 4% of the total cost. Thus, automation optimizes & streamlines NGS workflows.

https://www.meticulousresearch.com/download-sample-report/cp_id=1262

Based on geography, the genomics market is segmented into North America , Europe , Asia-Pacific , Latin America , and the Middle East & Africa . In terms of value, in 2024, North America is expected to account for the largest share of  of the genomics market. This market is projected to reach   by 2031. North America's dominant position in the genomics market is attributed to government initiatives toward the development of genomic medicine, the increased use of genomics since the COVID-19 pandemic, increasing research in the field of genomics, and the advanced healthcare infrastructure in the region.

 https://www.meticulousresearch.com/request-customization/cp_id=1262

In addition, North America is home to numerous renowned research institutions, universities, and organizations dedicated to genomics research—examples include the Broad Institute, Harvard University , MIT , and the National Institutes of Health (NIH) in the U.S., as well as the University of Toronto , McGill University , and the Ontario Institute for Cancer Research (OICR) in Canada . In North America , genomics is a multidisciplinary field encompassing research, technology development, and applications related to the study of genomes (complete sets of genes within an organism's DNA). In North America , genomics has been a significant and rapidly evolving field with broad applications in various areas of science and medicine.

In 2024, the U.S. is expected to account for the dominant share of of the genomics market in North America . The country's large market share is mainly attributed to the availability of advanced technologies & resources for healthcare, research funding, government initiatives to promote precision medicine, high public & private investments in genomics, and the availability of skilled professionals in the country.

The genomics market in Asia-Pacific is projected to register the highest CAGR of  % during the forecast period. In 2024, China is expected to account for the largest share of of the genomics market in Asia-Pacific . Economic growth in many Asia-Pacific countries has increased government focus on the healthcare sector in terms of investments aimed at improving access to healthcare facilities and building better healthcare infrastructure. Rapid urbanization, the need to manage the growing burden of infectious diseases, efforts to improve access to diagnostic services, and rising awareness regarding health and treatment availability are driving the growth of this market. Moreover, rising middle-class populations and their disposable incomes, increasing health insurance penetration, the growing potential of personalized therapies, and public and private investments are expected to support market growth during the forecast period.

Funding from public & private organizations for the development of innovative genomic medicine has increased China's focus on strengthening its genomics market.

:

This report offers a competitive analysis based on an extensive assessment of the leading players' product portfolios, geographic presence, and key growth strategies adopted over the past 3–4 years. Major companies in the genomics market have implemented various strategies to expand their product offerings and global footprints and augment their market shares. The key strategies followed by most companies in the genomics market include product launches, expansions, agreements, collaborations, and partnerships. The key players operating in the genomics market include 

The report includes a competitive dashboard that summarizes the market positions of the 20 profiled market players in four quadrants, namely Industry Leaders, Differentiators, Emerging Companies, and Vanguards. These companies are positioned based on various parameters, including revenue, depth of offerings, brand equity, geographic presence, innovation, and organic & inorganic growth strategies. Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V (U.S.), and Danaher Corporation (U.S.) were positioned in the Industry Leaders quadrant.

https://www.meticulousresearch.com/Checkout/61289368

Note: Other sequencing technologies include pyrosequencing, degradome sequencing, Sanger sequencing, Chromatin Immunoprecipitation (ChIP) sequencing, and methylation sequencing.

Note: (Other technologies include cell counting, transfection, and gene editing.)

https://www.meticulousresearch.com/download-sample-report/cp_id=1262

Note: Other life sciences research applications include cardiovascular diseases, osteoporosis, immunology, neurobiology, cellular & molecular biology, and diabetes research.

Note: Other applications include agriculture, forensics, and environmental applications.

Note: Other end users include food & beverage companies, agricultural companies, and forensics.

https://www.meticulousresearch.com/product/genomics-market-1262

- https://www.meticulousresearch.com/product/animal-genetics-market-5863

  - https://www.meticulousresearch.com/product/spatial-genomics-market-5763

- https://www.meticulousresearch.com/product/genetic-testing-market-5370

- https://www.meticulousresearch.com/product/ai-in-genomics-market-5345

- https://www.meticulousresearch.com/product/NGS-market-industry-outlook-5957

- https://www.meticulousresearch.com/product/ngs-automation-market-5271

- https://www.meticulousresearch.com/product/saudi-arabia-ngs-market-6002

- https://www.meticulousresearch.com/product/latin-america-ngs-market-5780

- https://www.meticulousresearch.com/product/asia-pacific-next-generation-sequencing-market-5722

- https://www.meticulousresearch.com/product/north-america-ngs-market-5607

Click here to: Get Free Sample Pages of this Report

- https://www.meticulousresearch.com/product/automated-material-handling-systems-market-5149

- https://www.meticulousresearch.com/product/healthcare-cybersecurity-market-5116

- https://www.meticulousresearch.com/product/direct-to-consumer-pet-food-market-5146

- https://www.meticulousresearch.com/product/haematococcus-pluvialis-market-5142

- https://www.meticulousresearch.com/product/south-east-asia-english-language-learning-market-5677

- https://www.meticulousresearch.com/product/interactive-display-market-5125

- https://www.meticulousresearch.com/product/semiconductor-and-circuit-manufacturing-market-5092

- https://www.meticulousresearch.com/product/automotive-powertrain-sensors-market-5155

- https://www.meticulousresearch.com/product/water-quality-testing-market-5501

- https://www.meticulousresearch.com/product/clear-aligners-market-5331

- https://www.meticulousresearch.com/product/testing-inspection-and-certification-market-5151

- https://www.meticulousresearch.com/product/power-tools-market-5810

- https://www.meticulousresearch.com/product/medical-lasers-market-5196

- https://www.meticulousresearch.com/product/laser-technology-market-5189

- https://www.meticulousresearch.com/product/dialysis-market-5137

- https://www.meticulousresearch.com/product/tertiary-water-and-wastewater-treatment-technologies-market-5185

- https://www.meticulousresearch.com/product/parking-management-market-5094

- https://www.meticulousresearch.com/product/dunaliella-salina-market-5168

- https://www.meticulousresearch.com/product/electric-car-market-5187

- https://www.meticulousresearch.com/product/pharmaceutical-contract-development-and-manufacturing-market-5171

- https://www.meticulousresearch.com/product/delivery-drones-market-5193

- https://www.meticulousresearch.com/product/electric-vehicle-market-5179

- https://www.meticulousresearch.com/product/iot-sensors-market-5738

- https://www.meticulousresearch.com/product/virtualized-evolved-packet-core-market-5201

- https://www.meticulousresearch.com/product/seaweed-market-5183

- https://www.meticulousresearch.com/product/dental-3d-printing-material-market-5204

- https://www.meticulousresearch.com/product/scada-market-5186

- https://www.meticulousresearch.com/product/iot-security-market-5254

- https://www.meticulousresearch.com/product/electric-scooter-market-5191

- https://www.meticulousresearch.com/product/canada-black-soldier-fly-market-5230

Contact:

1267 Willis St, Ste 200 Redding,
California , 96001, U.S.
: +1-646-781-8004
: +44-203-868-8738
: +91 744-7780008
Email- mailto:sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Meticulousblog.org | Top Market Research Reports Blog - https://meticulousblog.org/
Content Source: https://www.meticulousresearch.com/pressrelease/245/genomics-market

Photo: https://mma.prnewswire.com/media/2514303/Genomics_Market_Size.jpg
Logo: https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/genomics-market-to-reach-70-52-billion-by-2031--driven-by-increasing-incorporation-of-genomic-data-in-clinical-workflows-and-increasing-funding-and-investments-in-genomics-projects---exclusive-report-by-meticulous-research-302257400.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili